Atlas Trials

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Clinical trial NCT03826524 · RECRUITING

Trial details

NCT number
NCT03826524
Sponsor
Unity Health Toronto
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiac Arrest, Out-Of-HospitalSudden Cardiac ArrestVentricular FibrillationVentricular Tachycardia-Pulseless
Start date
2023-05-24
Primary completion
2027-12-01
Enrollment
3790

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.